Final Answer:
Recent use of a CYP1A2 inhibitor, such as fluoroquinolone antibiotics (e.g., ciprofloxacin), antiarrhythmics, or oral contraceptives, could lead to decreased metabolism of theophylline, potentially causing elevated levels and toxicity.
Step-by-step explanation:
Theophylline is primarily metabolized by cytochrome P450 (CYP450) enzymes in the liver, particularly CYP1A2. If a drug that inhibits CYP1A2 is recently used, it could lead to decreased theophylline metabolism, potentially resulting in elevated theophylline levels and increased risk of toxicity.
Drugs such as fluoroquinolone antibiotics (e.g., ciprofloxacin), certain antiarrhythmics, and oral contraceptives are known inhibitors of CYP1A2. Therefore, their recent use might impair the normal metabolism of theophylline, causing an accumulation of the drug in the body. Monitoring theophylline levels and adjusting the dosage in the presence of such inhibitors is crucial to avoid adverse effects and ensure therapeutic efficacy.